Clincosm LogoSign in Get a demo

urinary bladder neoplasms

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

Recruiting
  • Neoplasms
  • +13 more
  • HTL0039732 Capsules
  • HTL0039732 Capsules and atezolizumab infusion
  • Cambridge, United Kingdom
  • +4 more
Jul 5, 2023

Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

Not yet recruiting
  • Urinary Bladder Neoplasms
    • (no location specified)
    Feb 14, 2023

    Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

    Recruiting
    • Urinary Bladder Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Urinary Bladder Tumors, Tumor Metastasis, Ureteral Tumors Trial in New York, Myrtle Beach, Nashville (LOXO-435, Pembrolizumab)

    Recruiting
    • Urinary Bladder Neoplasms
    • +2 more
    • New York, New York
    • +2 more
    Jan 31, 2023

    Urinary Bladder Tumors Trial in Worldwide (TAR-200, Cetrelimab)

    Recruiting
    • Urinary Bladder Neoplasms
    • Phoenix, Arizona
    • +183 more
    Jan 27, 2023

    Urinary Bladder Tumors, Receptors, Fibroblast Growth Factor Trial in Japan (Erdafitinib Intravesical Delivery System)

    Not yet recruiting
    • Urinary Bladder Neoplasms
    • Receptors, Fibroblast Growth Factor
    • Erdafitinib Intravesical Delivery System
    • Kanagawa, Japan
    • +3 more
    Jan 27, 2023

    Urinary Bladder Tumors Trial in Worldwide (TAR-200, Cetrelimab)

    Recruiting
    • Urinary Bladder Neoplasms
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023

    Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

    Recruiting
    • Uterine Cervical Neoplasms
    • +10 more
    • Pembrolizumab/Vibostolimab Co-Formulation
    • +11 more
    • Anchorage, Alaska
    • +65 more
    Jan 27, 2023

    Avelumab First-Line Maintenance in Canadian People With Advanced

    Not yet recruiting
    • Urinary Bladder Neoplasms
    • +3 more
    • Avelumab first-line maintenance
    • Mississauga, Ontario, Canada
      Bayshore Specialty Rx
    Jan 24, 2023

    Urinary Bladder Tumors, Muscle-Invasive Bladder Cancer Trial in Worldwide (Nivolumab, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Urinary Bladder Neoplasms
    • Muscle-Invasive Bladder Cancer
    • Nivolumab
    • +2 more
    • Tucson, Arizona
    • +172 more
    Jan 25, 2023

    Urinary Bladder Tumors Trial in Worldwide (Nivolumab, BCG, BMS-986205)

    Completed
    • Urinary Bladder Neoplasms
    • Nivolumab
    • +2 more
    • Los Angeles, California
    • +88 more
    Jan 24, 2023

    Urinary Bladder Tumors Trial in Worldwide (Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy

    Recruiting
    • Urinary Bladder Neoplasms
    • Washington, District of Columbia
    • +120 more
    Jan 19, 2023

    Urinary Bladder Tumors Trial in Xi'an (drug, procedure, radiation)

    Not yet recruiting
    • Urinary Bladder Neoplasms
    • Tislelizumab Injection
    • +2 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Dec 26, 2022

    Urinary Bladder Tumors Trial in Worldwide (Durvalumab, Olaparib, Placebo)

    Active, not recruiting
    Has Results
    • Urinary Bladder Neoplasms
    • Birmingham, Alabama
    • +44 more
    Dec 21, 2022

    Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),

    Active, not recruiting
    • Carcinoma, Transitional Cell
    • +6 more
    • enfortumab vedotin (EV)
    • +4 more
    • Anchorage, Alaska
    • +105 more
    Dec 19, 2022

    Urinary Bladder Tumors Trial in Qingdao

    Recruiting
    • Urinary Bladder Neoplasms
      • Qingdao, Shandong, China
        Qilu Hospital of Shandong University (Qingdao)
      Dec 16, 2022

      Urinary Bladder Tumors Trial in Worldwide (drug, other, biological)

      Active, not recruiting
      • Urinary Bladder Neoplasms
      • Aurora, Colorado
      • +102 more
      Nov 16, 2022

      Urinary Bladder Tumors, Colorectal Cancer, NSCLC Trial in Worldwide (AZD8853, Zirconium-89 crefmirlimab berdoxam)

      Recruiting
      • Urinary Bladder Neoplasms
      • +2 more
      • AZD8853
      • Zirconium-89 crefmirlimab berdoxam
      • New Haven, Connecticut
      • +14 more
      Aug 8, 2022

      Urinary Bladder Tumors, Woman, Sexual Dysfunction, Physiological Trial in Guangzhou (POPRC+OIN, SRC+OIN)

      Not yet recruiting
      • Urinary Bladder Neoplasms
      • +4 more
      • POPRC+OIN
      • SRC+OIN
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital
      Apr 12, 2022

      Urinary Bladder Tumors Trial in München (Catumaxomab)

      Recruiting
      • Urinary Bladder Neoplasms
      • München, Germany
        Urologie Planegg
      Apr 4, 2022

      Lymphedema After Urologic Surgery

      Recruiting
      • Urinary Bladder Neoplasms
      • +2 more
      • Self-reported lymphedema
      • +2 more
      • Göteborg, Sweden
        Sahlgrenska University Hospital
      Mar 16, 2022

      Urinary Bladder Tumors Trial in San Antonio (AGEN1884, AGEN2034, Cisplatin)

      Active, not recruiting
      • Urinary Bladder Neoplasms
      • San Antonio, Texas
        Mays Cancer Center
      Mar 11, 2022

      Urinary Bladder Tumors Trial in Worldwide (Erdafitinib, Investigator Choice (Gemcitabine), Investigator Choice (Mitomycin C))

      Recruiting
      • Urinary Bladder Neoplasms
      • Tucson, Arizona
      • +178 more
      Mar 24, 2022

      Bladder Cancer Cell Transitional, Non-Muscle Invasive Bladder Cancer, Bladder Cancer Trial in United States (TSD-001)

      Completed
      • Bladder Cancer Cell Transitional
      • +9 more
      • Tucson, Arizona
      • +4 more
      Jan 18, 2022

      Urinary Bladder Tumors Trial in Pittsburgh (Magnetic Resonance Imaging, Gadobutrol intravesical administration (4mM),

      Recruiting
      • Urinary Bladder Neoplasms
      • Magnetic Resonance Imaging
      • +2 more
      • Pittsburgh, Pennsylvania
        UPMC Department of Urology
      Jan 7, 2022